![Michael Tomsicek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 36 287 $ in data 31/05/2026
Michael J. Tomsicek è un direttore non esecutivo indipendente di Milestone Pharmaceuticals, Inc. e un direttore finanziario e contabile principale di CRISPR Therapeutics AG. Fa parte del Consiglio di amministrazione di Milestone Pharmaceuticals, Inc. e Optimer Pharmaceuticals LLC. Tomsicek è stato precedentemente impiegato come CFO, Tesoriere, Principal Accounting Officer & VP presso ABIOMED, Inc., Tesoriere presso Cubist Pharmaceuticals, Inc., CFO-Global Ultrasound Product Group presso General Electric Healthcare Technologies, Inc., Manager-Commercial Finance & Business Planning presso Motorola Automotive & Industrial Electronics Group, e Chief Financial Officer presso The Lexington. È stato anche membro del consiglio di amministrazione di Trius Therapeutics, Inc. Si è laureato presso l'Università del Wisconsin e ha conseguito un MBA presso l'Università del Wisconsin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 15.001 ( 0,01% ) | 21 301 $ | 31/05/2026 | |
| 17/06/2026 | 9.366 ( 0,02% ) | 14 986 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 01/04/2019 |
| ACRIVON THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/10/2022 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Direttore/Membro del Consiglio | 24/10/2013 |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Direttore/Membro del Consiglio | 03/11/2022 |
| Società | Posizione | Fine |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore Finanziario/CFO | 14/10/2021 |
| ABIOMED, INC. | Direttore Finanziario/CFO | 24/08/2017 |
| CUBIST PHARMACEUTICALS INC | Direttore Finanziario/CFO | 01/01/2015 |
General Electric Healthcare Technologies, Inc.
 General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Corporate Officer/Principal | 01/09/2010 |
The Lexington
 The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Direttore Finanziario/CFO | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Health Services |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Health Services |
Motorola Automotive & Industrial Electronics Group | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
